Stem cells->Hematopoietic Progenitors->Surface Molecules;Microbiology->Interspecies Interaction->Host Virus Interaction;Cancer->Cancer Metabolism->Response to hypoxia;Cancer->Invasion/microenvironment->Apoptosis->Death receptors & ligands->RIP;Cancer->Invasion/microenvironment->Apoptosis->Death receptors & ligands->TRAIL;Cancer->Invasion/microenvironment->Apoptosis->Caspases;Cancer->Invasion/microenvironment->Apoptosis->Cytochrome C;Cancer->Invasion/microenvironment->Angiogenesis->Angiogenic growth factors;Cancer->Invasion/microenvironment->Angiogenesis->ECM enzymes->TIMPs;Cancer->Invasion/microenvironment->Angiogenesis->Angiogenic inhibitory factors;Cancer->Invasion/microenvironment->Angiogenesis->Other;Cancer->Invasion/microenvironment->Hypoxia->HIF;Cancer->Tumor biomarkers->Tumor antigens;Cancer->Oncoproteins/suppressors->Oncoproteins->Growth factor receptors;Cancer->Growth factors->VEGF;Metabolism->Pathways and Processes->Metabolism processes->Hypoxia;Metabolism->Types of disease->Cancer

P35968

The Protein has a calculated MW of 106.8kDa. As a result of glycosylation, the protein migrates to 115-140kDa based on Bis-Tris PAGE.

Human

Protein

> 95% as determined by Bis-Tris PAGE.
> 95% as determined by HPLC.

CD309 antigen; CD309; EC 2.7.10; EC 2.7.10.1; Fetal liver kinase 1; fetal liver kinase-1; Flk1; Flk-1; FLK1tyrosine kinase growth factor receptor; KDR; kinase insert domain receptor (a type III receptor tyrosine kinase); Kinase insert domain receptor; Protein-tyrosine kinase receptor flk-1; soluble VEGFR2; vascular endothelial growth factor receptor 2; VEGF R2; VEGFR; VEGFR2; VEGFR-21

The product should be stored at -70℃. Please do not repeated freeze-thaw cycles.